NCT01998152

Brief Summary

The purpose is to study the effect of individualized nutritional counselling compared to usual nutritional care on cross-sectional muscle area in patients with stage IV colorectal cancer during first line chemotherapy. Secondary, effect on total lean body mass, treatment intensity, physical functioning, quality of life and survival will be studied.We hypothesize that patients in the intervention arm benefit from individualized nutritional counseling.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
107

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

November 11, 2013

Completed
17 days until next milestone

First Posted

Study publicly available on registry

November 28, 2013

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2018

Completed
Last Updated

December 21, 2018

Status Verified

December 1, 2018

Enrollment Period

5.1 years

First QC Date

November 11, 2013

Last Update Submit

December 20, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in skeletal muscle area (cm2) between individualized nutritional counselling versus usual nutritional care

    will be measured with SliceOmatic software V5.0 (Tomovision) with use of routinely conducted CT scans for diagnostic and disease evaluation purposes

    During 9 weeks of first line chemotherapy

Secondary Outcomes (4)

  • Change in total body lean body mass and segmental lean body mass (DEXA) in patients with stage IV colorectal cancer during 9 weeks of first line chemotherapy between individualized nutritional counseling versus usual nutritional care

    During 9 weeks of first line chemotherapy

  • Change in skeletal muscle area in patients with stage IV colorectal cancer during 20 weeks of first line chemotherapy between individualized nutritional counseling.versus usual nutritional care.

    During 20 weeks of first line chemotherapy

  • Composite of treatment toxicity, treatment intensity, treatment outcome, survival, physical functioning, quality of life and hand grip strength of both study arms

    During 9 weeks and during 20 weeks of first line chemotherapy

  • Associations of (changes in) muscle area with (changes in) mid-upper arm muscle circumference, whole body fat free mass (BIA) and whole body lean body mass (DEXA).

    During 9 weeks of first line chemotherapy

Study Arms (2)

Nutritional counseling

EXPERIMENTAL

Individualized nutritional counselling by a registered dietitian

Procedure: Nutritional counseling

No intervention

NO INTERVENTION

Usual nutritional care by the oncologist. A dietitian is only involved when serious nutritional problems occur.

Interventions

Patients in the intervention-arm will receive individualized nutritional counseling by a registered dietitian during standard treatment with chemotherapy. The main goals of the nutritional intervention will be to enable every patient to achieve sufficient protein and energy intake with attention for sufficient intake of micronutrients and a sufficient physical activity level.

Nutritional counseling

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Stage IV colorectal cancer
  • Scheduled for treatment with first line chemotherapy, either CAPOX(-B), FOLFOX(-B) or capecitabine(-B)
  • CT scan suitable for evaluating muscle mass at L3 level
  • Understanding of the Dutch language
  • Able and willing to give written informed consent

You may not qualify if:

  • Chemotherapy in the previous three months
  • WHO performance status ≥ 3
  • Long-term high dose of corticosteroids: ≥ three weeks ≥ ten milligram prednisolon or equivalent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

VU Medical Center

Amsterdam, NL-1081 HV, Netherlands

Location

Amphia Hospital

Breda, 4819 EV, Netherlands

Location

Reinier de Graaf

Delft, 2625 AD, Netherlands

Location

Ziekenhuis Gelderse Vallei

Ede, 6716 RP, Netherlands

Location

Spaarne hospital

Hoofddorp, NL-2134 TM, Netherlands

Location

Related Publications (2)

  • van der Werf A, Langius JAE, Beeker A, Ten Tije AJ, Vulink AJ, Haringhuizen A, Berkhof J, van der Vliet HJ, Verheul HMW, de van der Schueren MAE. The effect of nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: A randomized controlled trial. Clin Nutr. 2020 Oct;39(10):3005-3013. doi: 10.1016/j.clnu.2020.01.009. Epub 2020 Jan 29.

  • van der Werf A, Blauwhoff-Buskermolen S, Langius JA, Berkhof J, Verheul HM, de van der Schueren MA. The effect of individualized nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: a randomized controlled trial protocol. BMC Cancer. 2015 Mar 5;15:98. doi: 10.1186/s12885-015-1092-5.

MeSH Terms

Conditions

Colorectal Neoplasms

Interventions

Nutrition Assessment

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Officials

  • M.A.E de van der Schueren, Dr.

    Amsterdam UMC, location VUmc

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Investigator dietetics and nutrition sciences Vumc

Study Record Dates

First Submitted

November 11, 2013

First Posted

November 28, 2013

Study Start

November 1, 2013

Primary Completion

December 1, 2018

Study Completion

December 15, 2018

Last Updated

December 21, 2018

Record last verified: 2018-12

Locations